Gw&K Investment Management, LLC Athersys, Inc Transaction History

Gw&K Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.18 - $0.86 $91,818 - $438,686	-510,100 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.6 - $1.06 $2,100 - $3,710	-3,500 Reduced 0.68%	510,100 $309,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.4 $6,630 - $10,920	-7,800 Reduced 1.5%	513,600 $464,000
Q3 2021 Nov 10, 2021	SELL	$1.33 - $1.77 $5,918 - $7,876	-4,450 Reduced 0.85%	521,400 $693,000
Q1 2021 May 11, 2021	SELL	$1.61 - $2.77 $10,787 - $18,559	-6,700 Reduced 1.26%	525,850 $947,000
Q4 2020 Feb 05, 2021	SELL	$1.55 - $2.24 $30,070 - $43,456	-19,400 Reduced 3.51%	532,550 $932,000
Q3 2020 Nov 10, 2020	SELL	$1.91 - $3.08 $38,582 - $62,216	-20,200 Reduced 3.53%	551,950 $1.08 Million
Q2 2020 Aug 06, 2020	BUY	$1.97 - $3.98 $88,847 - $179,498	45,100 Added 8.56%	572,150 $1.58 Million
Q1 2020 May 11, 2020	BUY	$1.17 - $3.0 $616,648 - $1.58 Million	527,050 New	527,050 $1.58 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.